New clinical trials are crucial in the fight against pancreatic cancer, providing patients with access to advanced treatments. The ongoing research aims to improve outcomes and address the unmet needs of those affected by the disease.
Clinical trials are essential for developing and approving new treatments for pancreatic cancer. Current treatment options include chemotherapy, immunotherapy, targeted therapy, and hormone therapy, with targeted therapy expected to gain significant market share by 2027. This approach focuses on specific proteins, genes, or tissues that contribute to cancer growth, aiming to block its progression.